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In drug formulations, cyclodextrins are used to increase aqueous solubility and chemical 
stability of drugs via formation of inclusion complexes. For ionizable drug molecules, the 
complexation strength depends on pH. Increased ionization leads to a more soluble drug, 
but also results in destabilization of cyclodextrin complexes. Therefore, formulation 
scientists aim to find a balance between increased drug solubility and high complexation 
strength. In this work, a theoretical expression for the dependency between the stability 
constant and pH is presented, allowing the accurate prediction of the stability constant at 
any pH. The theoretical expression requires three out of four input parameters; the pKa of 
the free guest molecule, the pKa of the complex, and the stability constants for the neutral 
and fully ionized complex. Stability constants for β-cyclodextrin and ibuprofen 
complexes were determined by isothermal titration calorimetry at seven pH values (2.5-
5.5) and four temperatures (15-55˚C). All these measured stability constants complied 
with the theoretical expression. Ten additional data sets from the literature comprising 
eight different drug molecules and three different cyclodextrins confirmed the ability of 
the theoretical expression to account for the observed pH-dependence of stability 
constants. 
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Cyclodextrins (CDs) are a widely used excipient in the pharmaceutical and food industries (Jansook 
et al., 2018; Kurkov et al., 2011). CDs are derived from starch, and consist of several (α-1,4)-linked 
glucopyranose units (Loftsson et al., 2007; Loftsson and Brewster, 1996). The natural and most 
common CDs are αCD, βCD and γCD, which consist of 6, 7 or 8 glucopyranose units, respectively. 5 
Modification of natural CDs has resulted in pharmaceutically relevant derivatives, including 
hydroxypropyl-βCD (HP-βCD) and sulfobutylether-βCD (SBE-βCD). CDs have a cone-like 
structure with a hydrophobic cavity and hydrophilic outer surface (Brewster and Loftsson, 2007). 
The application of CDs are based on their ability to form inclusion complexes in aqueous solutions 
(Astray et al., 2009; Jambhekar and Breen, 2016). Through complex formation, CDs can be used to 10 
increase solubility, hide unpleasant odor or taste, and improve the chemical stability of active 
molecules (Astray et al., 2009; Dargó et al., 2018; Junquera et al., 1998; Loftsson and Duchêne, 
2007; Perlovich et al., 2003). The ability to increase solubility is particularly important, as many 
potential drug molecules have low aqueous solubility (Williams et al., 2013). 
 15 
Interactions between CDs and drug molecules are often accompanied by pH regulation. Altering the 
pH is often used to increase aqueous solubility of potential drug molecules, because ionization 
affects the polarity (Williams et al., 2013). Many potential drugs are ionizable compounds, so their 
solubility depends on pH (Williams et al., 2013). Changes in pH can also affect the chemical 
stability, because degradation pathways are often affected by pH (Karow et al., 2013). To ensure the 20 
high quality of drug and food products, regulation of pH is essential. However, in drug formulations 
that include CDs, the pH affects the stability constant of the equilibrium between CDs and the guest 
molecule. The extent of the interaction between CD and guest molecule is governed by the stability 
constant, and is therefore important for the ability of CDs both to solubilize the guest and the 
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overall stability of the formulation. The balance between a high stability constant and a suitable 25 
solubility for any given formulation is a matter for optimization. Hence, it is important to have a 
thorough understanding of the relationship between the stability constant and pH. 
 
Several studies empirically describe the effect of pH on complex formation between CDs and 
ionizable guest molecules (e.g. Al Omari et al., 2006a; Danel et al., 2008; di Cagno, 2016; Jug et 30 
al., 2009; Kuwabara et al., 2006; López-Miranda et al., 2018; López-Nicolás et al., 2009; Perlovich 
et al., 2003). The equilibrium constant (K) for complex formation is affected by pH. The neutral 
form of a molecule generally forms a stronger complex than the ionized form, because the neutral 
molecule is more hydrophobic and has a higher affinity for the hydrophobic CD cavity. The 
relationship between the stability constant and pH has been reported for several guest molecules, 35 
including risperidone, pterostilbene, and ibuprofen (Jug et al., 2009; López-Nicolás et al., 2009; 
Perlovich et al., 2003). However, no quantitative theoretical relation between K and pH is 
published. A theoretical expression defining how the stability constant depends on pH allows one to 
predict how changes in pH affects the stability constant, and hence the stability of a formulation. 
 40 
The aim of the present work is to derive a theoretical expression for the stability constant as a 
function of pH and test its validity with various drug:CD complexes. The theoretical expression is 
potentially a valuable tool for formulation scientists who currently rely on general experience. It 
permits the determination of the stability constant at any degree of ionization of the guest molecule. 
To validate the theoretical expression, stability constants for a model system of β-CD and ibuprofen 45 
were determined at four temperatures and seven pH values. Ibuprofen was chosen as a model drug 
since it is known to form an inclusion complex with β-CD (Castronuovo and Niccoli, 2013; Waters 
et al., 2010; Xing et al., 2009). Ibuprofen is a monoprotic acid meaning that a neutral form of 
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ibuprofen exists at low pH and an ionized form exists at high pH. In addition, the theoretical 
expression was validated on ten published data sets found for different complexes between drugs 50 
and β-CDs. The ten data sets contain a total of eight different guest molecules and three different β-
CDs. 
 
2. Material and Methods 
2.1 Reagents 55 
Ibuprofen (CAS: 15687-27-1, ≥98%, Mw = 206.28 g/mol) and β-CD (CAS: 7585-39-9, ≥97%, Mw = 
1134.98 g/mol) was purchased from Sigma-Aldrich and used as received. All other chemicals used 
were of analytical grade. 
 
2.2 pKa determination 60 
Determination of pKa for ibuprofen and the β-CD:ibuprofen complex was carried out using the 
Sirius T3 titrator (Sirius Analytical Instruments Ltd, East Sussex, UK), measuring the UV-VIS 
spectrum during titration. Experiments were conducted at 25˚C. The ionic strength was kept 
constant by using water containing 0.15 M potassium chloride. The pKa of the complex was 
determined in water, and the pKa of ibuprofen was, due to poor solubility, determined using DMSO 65 
as a co-solvent and extrapolated to 0% co-solvent by the Yasuda-Shedlowsky method. All data 
were processed using the accompanying Sirius software.  
 
2.3 Isothermal Titration Calorimetry 
Isothermal Titration Calorimetry (ITC) was used to determine the stability constant for 70 
complexation between β-CD and ibuprofen at seven different pH values from 2.5-5.5 at 0.5 pH unit 
intervals and at four different temperatures: 15, 25, 40, and 55˚C. Both β-CD and ibuprofen were 
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prepared in 50 mM sodium acetate buffer. The pH of the solution was adjusted at room temperature 
with either 1 M NaOH or 10% HCl to obtain the desired pH value. The pKa value of acetate buffer 
has been shown to change very little within the temperature range used in this study (Fukada and 75 
Takahashi, 1998), thus this change was neglected. As ibuprofen has a low solubility in water, 
concentrations in the range 0.2-0.5 mM were used, depending on the pH of the buffer. The 
concentration of β-CD in each experiment was 10 times the concentration of ibuprofen. ITC 
measurements were performed using a MicroCal VP-ITC MicroCalorimeter (Malvern Panalytical, 
Worcestershire, UK). Ibuprofen solution was loaded into the calorimetric cell, having a total 80 
volume of 1.4257 mL. The 250-µL injection syringe was loaded with β-CD. Titrations were carried 
out by adding 10 µL titrant (except for the first injection which was 4 µL) until the syringe was 
emptied. The titrant was injected during 20 s with an interval of 300 s between injections to ensure 
return to baseline. The stirring speed was 310 rpm. The heat of dilution was corrected for by 
subtracting the heat signal for a blank titration of titrant into buffer without ibuprofen. After 85 
collection of a complete data set for a specific pH value, i.e. ITC data for all five temperatures, the 
data was globally fitted using an in-house MatLab script that assumes that the temperature 
dependence of the binding constant was governed by the van’t Hoff equation (Schönbeck et al., 
2012). 
 90 
3. Results  
3.1 ITC determination of stability constant for the ibuprofen:β-CD complex 
Data from several ITC experiments are presented in Figure 1. Using the MatLab script, the data was 
curve-fitted to yield the stability constant and the reaction enthalpy. The experiments were 
performed at several pH values and at 15, 25, 40, and 55°C, which means that 35 titrations were 95 
performed. The stability constant depended on both temperature and pH (Fig. 2). The van’t Hoff 
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equation describes the temperature-dependency of the stability constant, which decreased with 
increasing temperature. There was a good fit between theoretical van’t Hoff calculations and data 
obtained by ITC, which indicated reliable data since the van’t Hoff expression can be used as an 
internal check of calorimetric data (Kantonen et al., 2018). The stability constant was 1.06 × 104 M-100 
1 at 25˚C and pH 5.5. This value corresponds to published values which range from 0.7 to 1.9 × 104 
M-1 at values of pH where ibuprofen was un-ionized (Bertaut and Landy, 2014; Cirri et al., 2006; di 
Cagno et al., 2011; Hergert and Escandar, 2003; Manzoori and Amjadi, 2003; Mura et al., 1998; 
Waters et al., 2010; Xing et al., 2009). One study reported a higher value of 5.0 × 104 M-1 at pH 7.4 
(Castronuovo and Niccoli, 2013). The binding enthalpy was determined to be -16.5 kJ/mol, which 105 
was consistent with the published value of -14.0 kJ/mol for the same system (Bertaut and Landy, 
2014). The heat capacity was -402 J/mol/K in the present study, which is consistent with the -394 
J/mol/K previously reported (Bertaut and Landy, 2014). 
 
3.2 pKa determination of ibuprofen and ibuprofen:β-CD complex 110 
The pKa values for ibuprofen and the ibuprofen:β-CD complex were determined from changes in 
the UV spectrum during a titration (Fig. 3). As a compound becomes charged, the UV absorbance 
changes, which allows the determination of pKa. The measured pKa for ibuprofen was 4.53, which 
was consistent with the pKa range of 4.4-5.2 reported in the literature (Avdeef, 2007; Avdeef et al., 
2000; Loftsson and Brewster, 1996; Perlovich et al., 2003). The measured pKa for the ibuprofen:β-115 
CD complex was 4.70. This was expected to differ from the pKa value for free ibuprofen due to its 
interaction with CD. 
 
3.3 Theoretical expression for the stability constant as function of pH 
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It is essential to understand the effect of pH on CD:drug complexation, as many drugs are ionizable, 120 
are thus sensitive to changes in pH. A theoretical expression will allow scientists to predict this 
sensitivity. A theoretical expression for the stability constant, KB, as a function of pH can be 
derived from physical chemical principles. Reactions between drugs and CDs are equilibrium 
reactions. 
𝐷𝐷 + 𝐶𝐶𝐷𝐷 ⇌  𝐷𝐷:𝐶𝐶𝐷𝐷    (1) 125 
The equilibrium constant, often referred to as the stability constant, for CD complexes, can be 
expressed in terms of the concentrations of the reacting species. 
𝐾𝐾𝐵𝐵 =  
[𝐷𝐷:𝐶𝐶𝐷𝐷]
[𝐷𝐷][𝐶𝐶𝐷𝐷]
      (2) 
For ionizable compounds with one pKa value, equilibria can be written for both neutral and ionized 
species. 130 
𝐻𝐻𝐷𝐷 + 𝐶𝐶𝐷𝐷 ⇌ 𝐻𝐻𝐷𝐷:𝐶𝐶𝐷𝐷   (3) 
𝐷𝐷− + 𝐶𝐶𝐷𝐷 ⇌ 𝐶𝐶𝐷𝐷:𝐷𝐷−   (4) 
Where HD represents the neutral form of the drug, and D- represents the charged form. 
Correspondingly, also two equilibrium constants also exist. 
𝐾𝐾𝑛𝑛𝑛𝑛𝑛𝑛 =  
[𝐻𝐻𝐷𝐷:𝐶𝐶𝐷𝐷]
[𝐻𝐻𝐷𝐷][𝐶𝐶𝐷𝐷]
    (5) 135 
 𝐾𝐾𝑖𝑖𝑖𝑖𝑛𝑛 =  
[𝐶𝐶𝐷𝐷:𝐷𝐷−]
[𝐷𝐷−][𝐶𝐶𝐷𝐷]
   (6) 
Thus, the overall stability constant for the drug can be expressed as follows. 


















   (7) 
Parts of the equation can be substituted with the terms Kneu and Kion. 140 
𝐾𝐾𝐵𝐵 =  
[𝐻𝐻𝐷𝐷]
[𝐻𝐻𝐷𝐷]+[𝐷𝐷−]
𝐾𝐾𝑛𝑛𝑛𝑛𝑛𝑛 +  
[𝐷𝐷−]
[𝐻𝐻𝐷𝐷]+[𝐷𝐷−]
𝐾𝐾𝑖𝑖𝑖𝑖𝑛𝑛   (8) 
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The concentrations of the neutral and charged drug are equal to the total concentration of the drug, 
also referred to as the formal concentration of the drug. 
𝐶𝐶𝐷𝐷 = [𝐻𝐻𝐷𝐷] + [𝐷𝐷−]   (9) 




    (10) 
This allows the theoretical expression to be further simplified. 
𝐾𝐾𝐵𝐵 = (1 − 𝛼𝛼)𝐾𝐾𝑛𝑛𝑛𝑛𝑛𝑛 +  𝛼𝛼𝐾𝐾𝑖𝑖𝑖𝑖𝑛𝑛  (11) 
This demonstrates how the equilibrium constant of the drug:CD complex can be expressed as a 
function of the dissociation degree and the equilibrium constants for the neutral and charged 150 
drug:CD complex. The dissociation degree of the drug depends on the pH. The dissociation degree 
can be expressed in terms of the ionized and neutral form of the drug. 
1 𝛼𝛼� =  1 [𝐷𝐷−]
𝐶𝐶𝐷𝐷







+ 1   (12) 
The ionized and neutral form of the drug represents the base and acid, and the Henderson-
Hasselbalch equation describes how the pH is correlated with the concentrations of the acid and 155 
base forms of the drug. 
𝑝𝑝𝐻𝐻 = 𝑝𝑝𝐾𝐾𝑎𝑎 + 𝑙𝑙𝑙𝑙𝑙𝑙
[𝑏𝑏𝑎𝑎𝑏𝑏𝑛𝑛]
[𝑎𝑎𝑎𝑎𝑖𝑖𝑎𝑎]
= 𝑝𝑝𝐾𝐾𝑎𝑎 + 𝑙𝑙𝑙𝑙𝑙𝑙
[𝐷𝐷−]
[𝐻𝐻𝐷𝐷]
   (13) 
[𝐷𝐷−]
[𝐻𝐻𝐷𝐷]
= 10𝑝𝑝𝐻𝐻−𝑝𝑝𝑝𝑝𝑎𝑎    (14) 
[𝐻𝐻𝐷𝐷]
[𝐷𝐷−]
= 10𝑝𝑝𝑝𝑝𝑎𝑎−𝑝𝑝𝐻𝐻  
By combining these expressions, it is possible to express KB as a function of pH with the pKa, Kion 160 
og Kneu. 
𝐾𝐾𝐵𝐵 = �1 − �1 (10𝑝𝑝𝑝𝑝𝑎𝑎−𝑝𝑝𝐻𝐻 + 1)� ��𝐾𝐾𝑛𝑛𝑛𝑛𝑛𝑛 + �
1
(10𝑝𝑝𝑝𝑝𝑎𝑎−𝑝𝑝𝐻𝐻 + 1)� �𝐾𝐾𝑖𝑖𝑖𝑖𝑛𝑛 (15) 
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This expression can predict how KB depends on pH for a monoprotic acid with a 1:1 binding 
mechanism between CD and drug. A similar expression exists for a monoprotic base. 
𝐾𝐾𝐵𝐵 = �1 − �1 (10𝑝𝑝𝐻𝐻−𝑝𝑝𝑝𝑝𝑎𝑎 + 1)� ��𝐾𝐾𝑛𝑛𝑛𝑛𝑛𝑛 + �
1
(10𝑝𝑝𝐻𝐻−𝑝𝑝𝑝𝑝𝑎𝑎 + 1)� �𝐾𝐾𝑖𝑖𝑖𝑖𝑛𝑛 (16) 165 
It is necessary to experimentally determine pKa, Kion and Kneu according to the theoretical 
expression. The binding equilibria for the ionized and the neutral species are linked by protonation 
reactions, and this equilibria diagram shows the relationship between Kneu, Kion, Ka and K’a, and it 
can be expressed mathematically. 
𝐾𝐾𝑛𝑛𝑛𝑛𝑛𝑛𝐾𝐾𝑎𝑎′ = 𝐾𝐾𝑖𝑖𝑖𝑖𝑛𝑛𝐾𝐾𝑎𝑎   (17) 170 
The relationship between Kneu, Kion and the two pKa terms has been published (Connors and Lipari, 
1976). This link is important as it demonstrates that the pH dependence of KB can also be expressed 
in terms of the two pKa values and either Kion or Kneu. 
 
Theoretically, it is possible to predict the stability constant at any pH by using Eq. 15 or 16. To use 175 
the theoretical expression, three out of the four parameters in Eq. 17 must be known; i.e., the pKa 
values of the free and bound guest molecule, and the equilibrium constants for the binding of the 
neutral and ionized guest. 
 
4. Discussion 180 
4.1 Empirical confirmation of theoretical expression based on ibuprofen:β-CD 
11 
 
The stability constant for ibuprofen:β-CD was used to confirm the theoretical expression derived 
above (Eq. 15). The results showed a nice correlation between the theoretical expression and the 
empirical data (Fig. 4). The three input parameters in the theoretical expression are Kneu, Kion and 
pKa for free ibuprofen. Kneu and Kion were estimated based on the relationship between K and the 185 
ionization degree at different pH values (Eq. 11). The pKa value of ibuprofen was 4.53. The results 
showed that at higher pH, where ibuprofen was ionized, the tendency to form complexes was lower. 
This has also been reported for other acidic compounds (Al Omari et al., 2006). 
 
As described in section 3.2, the theoretical expression requires three input parameters. In this study, 190 
we have mainly used Kneu, Kion and pKa for the free molecule. In theory (Eq. 17), the theoretical 
expression will yield the same result no matter which three out of the possible four input parameters 
are chosen. In the example with ibuprofen:β-CD, the measured stability constants show a difference 
of 0.3 pH units between the pKa value of the free guest molecule and the pKa value of the complex 
(Eq. 17). However, the pKa value of ibuprofen was determined to be 4.53, and the pKa value of the 195 
complex was determined to be 4.70, resulting in a difference of only 0.17 pH units. A small change 
in either pKa value will affect the theoretical expression. It is common that pKa values reported in 
the literature differ by up to 0.8 pH units, thus using these value will yield uncertain predictions of 
the stability constant as function of pH. Therefore, we suggest using Kneu, Kion and pKa of the free 
molecule as input parameters. 200 
 
4.2 Comparison of theoretical expression with empirical data sets from the literature 
The theoretical expression relies on physical chemical principles, and should be valid for all CD 
complexes. In this work, the theoretical expression was verified for complexes with β-CD, HP-β-
CD and SBE-β-CD (shown in Figs. S1-S4). Several studies were found in the literature where the 205 
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stability constant for the neutral and ionized drug:CD complex was presented along with the pKa 
value of the drug. Four complexes are presented (Table 1) fully in the main text, whereas additional 
six examples can be found in the supplementary material (Figs. S1-S4). The examples comprise 
drug:CD complexes with significant difference in the chemical structure and physicochemical 





Table 1. Published stability constants at specific pH values and the corresponding ionization degree of the molecules 
for three CD complexes. The ionization degree was calculated from the reported pKa values. 
Complex pH Stability constant Ionization degree (%) 
Pizotifen:β-CD (pKa = 8.9) 
















Ketotifen:β-CD (pKa = 8.5) 
















Ibuprofen:HP-β-CD (pKa = 4.41) 




















Based on the data published in these studies, the theoretical dependence of the stability constant as a 
function of pH for these complexes was successfully predicted. 
 
Both pizotifen and ketotifen can both form complexes with β-CD (Al Omari et al., 2008). Complex 
formation was investigated at pH; 3.4, 5.9, 6.8, 7.2, 8.7, 11.7 and 12.1 covering the neutral and fully 220 
ionized form of the compounds with pKas of 8.9 and 8.5, respectively (Al Omari et al., 2008). The 
pKa values as well as Kneu and Kion for pizotifen and ketotifen (values presented in Table 1) were 
used to plot the theoretical expression (Eq. 16). The measured stability constants for pizotifen:β-CD 
were in agreement with the plotted theoretical expression, while the stability constants for 
ketotifen:β-CD showed small deviations (Fig. 5). It is common for reported stability constants to 225 
vary for the same complex, particularly when different experimental methods are used in the 
14 
 
determination. Thus the small deviations from the theoretical expression are well within an 
acceptable variation. Other examples of pH-dependent complexation for similar complexes can be 
found in the supplementary material (Figs. S1-S4). The theoretical expression (Eq. 15 and 16) was 
well fitted by all presented empirical data sets.  230 
 
The theoretical expression assumes a simple equilibrium reaction between CD and the guest 
molecule. The derivatives of the natural CDs, e.g. HP-β-CD, have a more complicated structure 
because the substitution of the hydroxyl groups on β-CD is random (Jansook et al., 2018). Thus, a 
solution of HP-β-CD consists of an isomeric mixture of different HP-β-CDs. The same principle 235 
holds for other derivatives of the natural CDs, e.g., SBE-β-CD. However, the stability constant of 
complexes with HP-β-CD is measured as a bulk stability constant and represents an average 
stability constant, thus the theoretical expression is still valid. The published stability constant for 
risperidone:HP-β-CD is measured at five different pH-values (Jug et al., 2009), and the theoretical 
expression was in agreement with the empirical data (Fig. S5). The same conclusions are valid for 240 
7-hydroxy-4-methylcoumarin:SBE-β-CD, where the theoretical expression was consistent with the 
empirical data (Fig. S4). According to these data, the theoretical expression can also be verified for 
derivatives of β-CD complexes. In principle, the theoretical expression should apply to complexes 
with α-CDs and γ-CDs as well, but the present study is limited to β-CDs. 
 245 
The stability constant for ibuprofen:HP-β-CD is described in the literature (Perlovich et al., 2003). 
The stability constant was reported for the pH range 3.2-8.0, and the empirical data were used to 
find the theoretical dependency (Eq. 15) for the complex as a function of pH (Fig. 6). Input 
parameters used were Kion, Kneu and pKa. Kneu was not reported, because at pH 3.2, only 94.2 % of 
ibuprofen will be neutral. This will cause some error resulting in a discrepancy between the 250 
15 
 
empirical data and the theoretical expression. All data points were systematically to the right of the 
theoretical expression line when using the reported pKa value of 4.41 (Fig. 6, solid line). This 
indicated that the pKa value used as input in the theoretical expression was lower than the actual 
pKa value in the experiment. The reported pKa value for ibuprofen varies in the range 4.4-5.2 
(Avdeef, 2007; Avdeef et al., 2000; Loftsson and Brewster, 1996; Perlovich et al., 2003). Variation 255 
in pKa values for a compound is common, and may result from differences in the experimental 
method used (Mioduszewska et al., 2017). Variation can also be due to difference in the chemical 
environment, e.g. tonicity of the solution. By changing the pKa value used in the theoretical 
expression from 4.41 to 4.90 (Fig. 6, dashed line), a better agreement with the published data was 
obtained. Uncertainties in pKa values and stability constants will significantly affect results from the 260 
theoretical expression, as these constants are used as input parameters in the expression (Eq. 15 and 
16). Accurate estimates of these constants must be known to receive an accurate prediction using 
the theoretical expression. Published values for the pKa value often vary, and can be influenced by 
factors such as the presence of background electrolytes or co-solvents (Samuelsen et al., 2019). 
Thus, it is important to recognize and match all experimental conditions to improve the accuracy of 265 
the predicted values. 
 
All compounds investigated above showed a good agreement between the theoretical expression 
and the published empirical data. In total, ten complexes were investigated consisting of eight 
compounds bound to one of three different β-CDs. The eight compounds have different molecular 270 
weights and physicochemical properties. Results with all compounds showed that the neutral form 
of a molecule has a higher stability constant than the ionized form. Ionized molecules have a higher 
solubility in water due to their hydrophilic nature, and thus stability constants for complexation 
between ionized guests and CDs are expected to be lower as the cavities of CDs are hydrophobic. A 
16 
 
few studies have reported results contradicting this behavior, i.e. where there is no clear relationship 275 
between the ionization degree and the stability constant (Al Omari et al., 2009, 2007, 2006). When 
investigating these examples closer, it is seen that this contradictory behavior seems to be connected 
to the use of citrate buffer. However, there might be other reasons for why these few examples 
differ. The general trends from the literature are in agreement with the theoretical expression 
presented in this work. 280 
 
How the stability constant varies with pH for CD complexes is of interest for pharmaceutical 
scientists, as this knowledge can be used during drug formulation with CDs and helps to ensure that 
a robust formulation is defined. Regulation of pH and the addition of CDs are two strategies used to 
increase solubility of poorly soluble compounds. Ionizing the drug molecule by changing pH will 285 
increase its solubility. The use of CDs to increase solubility is another strategy. Often a combination 
of these strategies is used. However, the pH of a solution will affect the stability constants, i.e. the 
strength of the interaction between CD and guest molecule, as described above. An increase in 
ionization by changing the pH, leads to an improved aqueous solubility, but also to the 
destabilization of CD complexes. During drug formulation, it is necessary to find the optimal pH of 290 
a solution, so there is a balance between the aqueous solubility and the stability constant. By 
applying the theoretical expression, it is possible to identify the stability constant at any pH value. 
This will make it easier to find the optimal pH of a solution as the pH can be manipulated during 
formulation. The theoretical expression can also be applied during processing of potential drug 
formulations. During processing, products are often exposed to varying temperatures, which can 295 
affect the buffer pH (Samuelsen et al., 2019). An example is Tris buffer, which is commonly used 
in the pharmaceutical industry, although it is very sensitive to changes in temperature. It has a pKa 
of 8.06, and when temperature increases (e.g. during autoclaving), the pKa value decreases, 
17 
 
resulting in a decrease in solution pH. As shown in the present work, a change in pH will affect the 
stability constant of CD complexes. 300 
 
5. Conclusions 
The stability constants for CD complexes with ionizable guest molecules depend on pH. Based on 
chemical equilibrium principles, a theoretical expression for the pH dependence of the stability 
constant was derived. To use the theoretical expression for a specific CD complex, three of the four 305 
following parameters must be experimentally determined; the pKa values of the free and bound 
guest molecule, and the equilibrium constants for the binding of the neutral and ionized guests, 
respectively. Knowing all these inputs allows for accurate prediction of the binding constant at all 
pH values. 
ITC data for complex formation between ibuprofen and β-CD confirms the accuracy of the derived 310 
theoretical expression. Furthermore, the use of ten data sets from independent published studies 
with various drug molecules and three types of β-CDs confirm the accuracy of the theoretical 
expression. 
The theoretical expression has the potential to aid formulation scientists when finding the optimal 
pH value for a formulation containing CDs. 315 
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Figure 1. ITC data for a titration of β-CD into ibuprofen at pH 5.5 and 25°C. The x-axis represents 450 
the molar ratio of the formed complex, and the y-axis shows the heat. This a representative example 
of the ITC data generated.  
Figure 2. Measured stability constants as a function of pH at 15, 25, 40, and 55˚C for complex 
formation between ibuprofen and β-CD. 
Figure 3. UV absorbance of ibuprofen:β-CD complex during titration. This is a representative 455 
example of pKa data obtained from Sirius T3 titrator. 
Figure 4. Stability constants at several pH values for complex formation between ibuprofen and β-
CD determined by ITC (diamonds). The theoretical expression (solid line) is based on the stability 
constant of the neutral and ionized complex as well as the pKa value of ibuprofen (4.53). 
Figure 5. Complex formation between pizotifen (A) and ketotifen (B) with β-CD, respectively, at 460 
various pH values as reported by Al Omari et al. (2008a). The stability constants for the neutral and 
ionized species as well as the pKa values are used to calculate the theoretical expression (solid line) 
for the specific complexes. 
Figure 6. Complex formation between Ibuprofen and HP-β-CD at several pH values published by 
Perlovich et al. (2003). The theoretical expression (solid line) is based on the stability constants for 465 
the neutral and ionized form of the complex and the pKa value of 4.41 reported by Perlovich et al. 
(2003) and a pKa of 4.90 (dashed line). 
